Veterinary diagnostics VetLab consumables revenue measures recurring sales of test consumables used on IDEXX VetLab diagnostic instruments.
IDEXX reported $430.3M of VetLab consumables revenue in the second quarter of 2026, up 14.7% year over year.
Consumables monetize the installed instrument base
A placed instrument can generate recurring revenue as veterinary practices run more patient samples and more tests per sample.
That links consumables revenue directly to the size and utilization of the premium instrument installed base.
Revenue growth can outpace clinic visits
IDEXX said volume gains reflected testing by existing customers, an expanded test menu, and installed-base growth.
That is why weak same-store clinical visit growth does not necessarily imply weak consumables growth.
Primary source: IDEXX Q2 2026 Form 10-Q.
Part of the Veterinary Diagnostics Economics
See It in Company Research
These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.
- IDXXOpen operating-model research →10 of 10 reviewed concepts in Veterinary Diagnostics EconomicsRecurring diagnostic revenue engine4 of 4 bridge concepts supportedContinue through this bridge:CAG Recurring RevenueCAG Recurring Revenue GrowthReference Laboratory Revenue
Continue Research
Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.
Compare point-of-care consumables revenue
Compare recurring diagnostic consumables revenue with installed-base growth, test utilization, menu expansion, and realized price in context.
Explore more topics in the Financial Research Encyclopedia.